Search results

Showing 1 – 2 of 2 results.
Curated

Epidemiologic Catchment Area Program Sites 1-4, 1979-1983 with National Death Index Data through 2007 (ICPSR 36621)

Released/updated on: 2017-10-17
Geographic coverage: North Carolina, Baltimore, New Haven, United States, Connecticut, Missouri, St. Louis, Durham, Maryland
Time period: 1979-01-01--1982-01-01, 1980-01-01--1983-01-01, 1979-01-01--2007-01-01

The Epidemiologic Catchment Area (ECA) program of research was initiated in response to the 1977 report of the President's Commission on Mental Health. The purpose was to collect data on the prevalence and incidence of mental disorders and on the use of and need for services by the mentally ill. Independent research teams at five universities (Yale University, Johns Hopkins University, Washington University, Duke University, and University of California at Los Angeles), in collaboration with the National Institute for Mental Health, conducted the studies with a core of common questions and sample characteristics. The sites were areas that had previously been designated as Community Mental Health Center catchment areas: New Haven, Connecticut, Baltimore, Maryland, St. Louis, Missouri, Durham, North Carolina, and Los Angeles, California. Each site sampled over 3,000 community residents and 500 residents of institutions, yielding 20,861 respondents overall. The longitudinal ECA design incorporated two waves of personal interviews administered one year apart and a brief telephone interview in between (for the household sample). The diagnostic interview used in the ECA was the NIMH Diagnostic Interview Schedule (DIS), Version III (with the exception of the Yale Wave I survey, which used Version II). Diagnoses were categorized according to the DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, 3rd Edition (DSM-III). Diagnoses derived from the DIS include manic episode, dysthymia, bipolar disorder, single episode major depression, recurrent major depression, atypical bipolar disorder, alcohol abuse or dependence, drug abuse or dependence, schizophrenia, schizophreniform, obsessive compulsive disorder, phobia, somatization, panic, antisocial personality, and anorexia nervosa. The DIS uses the Mini-Mental State Examination (MMSE), which measures cognitive functioning, as an indirect measure of the DSM-III Organic Mental Disorders. In the ECA survey, this diagnosis is called cognitive impairment.

This collection features data from 17,327 participants across 2,005 variables. Data from the Los Angeles, California, Catchment (UCLA) are not included. Baseline data (Wave 1) and Wave 2 data were linked to the National Death Index through 2007, which includes primary and contributing causes of death, International Classification of Disease (ICD) codes, and nature of injury variables.

Curated

Mental and Substance Use Disorders Prevalence Study (MDPS), United States, 2020-2022 (ICPSR 38953)

Released/updated on: 2024-02-12
Geographic coverage: United States
Time period: 2019-10-01--2022-10-01
The Mental and Substance Use Disorders Prevalence Study (MDPS) is a pilot program designed to estimate the prevalence of specific mental and substance use disorders among U.S. adults 18-65 years of age. The MDPS is also designed to estimate the percentage of individuals with these specific mental and substance use disorders who receive treatment. The study is funded by SAMHSA. To estimate the prevalence of specific mental and substance use disorders, the MDPS design addresses two gaps in prior general population survey efforts: (1) the exclusion of institutionalized populations at high risk for disorders, and (2) the reliance on nonclinical or screening scales to estimate mental and substance use disorders. The specific disorders of interest measured in the MDPS are past 12-month and lifetime schizophrenia spectrum disorders (defined as including schizophrenia, schizoaffective disorder, or schizophreniform), past 12-month bipolar I disorder, major depressive disorder (MDD), generalized anxiety disorder (GAD), posttraumatic stress disorder (PTSD), obsessive-compulsive disorder, anorexia nervosa, and past 12-month alcohol, opioid, cannabis, stimulant, and sedative/hypnotic/anxiolytic use disorders. The MDPS sample included individuals residing in the residential household population and in three non-household populations: state/federal prisons, state psychiatric hospitals, and homeless shelters. The MDPS also utilizes the Structured Clinical Interview for DSM-5 (SCID-5; First et al., 2015), delivered by trained mental health clinicians, which is the gold standard for mental and substance use disorder diagnostic assessment. The MDPS was a cooperative agreement between RTI International and Substance Abuse and Mental Health Services Administration (SAMHSA).